Skip to content

E. Pereira

3 papers in the library · 1,431 citations · publishing 2018-2022

Papers

Sort Most recent Most cited

Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor

Nature Neuroscience August 30, 2022 Polymnia Georgiou, Panos Zanos, Ta-Chung M. Mou et al.

We show that the sex of human experimenters affects mouse behaviors and responses following administration of the rapid-acting antidepressant ketamine and its bioactive metabolite (2R,6R)-hydroxynorketamine. Mice showed aversion to the scent of male experimenters, preference for the scent of female experimenters and increased stress susceptibility when handled by male experimenters. This...

Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function

Proceedings of the National Academy of Sciences February 22, 2019 E. Lumsden, Timothy A. Troppoli, S. J. Myers et al. 159 citations

Significance Standard antidepressant treatments require weeks to show effectiveness. A single subanesthetic dose of ketamine rapidly attenuates many clinical signs and symptoms of depression; however, ketamine treatment also has many adverse effects, including dissociation and potential for abuse, which are mediated by NMDA glutamate receptor (NMDAR) inhibition. Previous work has revealed that...

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

Pharmacological Reviews June 26, 2018 Panos Zanos, Ruin Moaddel, Patrick J. Morris et al. 1,272 citations

Ketamine, a racemic mixture consisting of (S)- and (R)-ketamine, has been in clinical use since 1970. Although best characterized for its dissociative anesthetic properties, ketamine also exerts analgesic, anti-inflammatory, and antidepressant actions. We provide a comprehensive review of these therapeutic uses, emphasizing drug dose, route of administration, and the time course of these...